UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
THR
2176
DELISTED
Thermon Group Holdings
THR
| $379K | ﹤0.01% |
26,025
+1,405
| +6% | +$20.8K |
|
2177
Park Aerospace
PKE
$819M
| $378K | ﹤0.01% |
33,962
+18,900
| +125% | +$235K |
|
2178
Prothena Corp
PRTA
$459M
| $378K | ﹤0.01% |
36,107
-6,258
| -15% | -$69.5K |
|
2179
AnaptysBio
ANAB
$1.68B
| $377K | ﹤0.01% |
16,873
+2,524
| +18% | +$46.1K |
|
2180
Corbus Pharmaceuticals
CRBP
$188M
| $375K | ﹤0.01% |
+1,490
| New | +$301K |
|
2181
Ecovyst
ECVT
$1.14B
| $374K | ﹤0.01% |
28,282
+14,560
| +106% | +$171K |
|
|
SPNS
2182
DELISTED
Sapiens International
SPNS
| $370K | ﹤0.01% |
13,207
| – | – |
|
|
MCHB
2183
Mechanics Bancorp
MCHB
$3.68B
| $369K | ﹤0.01% |
14,975
| – | – |
|
2184
Apogee Enterprises
APOG
$908M
| $368K | ﹤0.01% |
15,956
| – | – |
|
2185
Horizon Bancorp
HBNC
$1.04B
| $366K | ﹤0.01% |
34,204
+24,185
| +241% | +$247K |
|
|
MSGN
2186
DELISTED
MSG Networks Inc.
MSGN
| $365K | ﹤0.01% |
36,726
-6,535
| -15% | -$74.6K |
|
2187
Axogen
AXGN
$2.5B
| $365K | ﹤0.01% |
39,529
-1,127
| -3% | -$10.1K |
|
|
VRS
2188
DELISTED
Verso Corporation
VRS
| $365K | ﹤0.01% |
30,538
-2,872
| -9% | -$37.6K |
|
|
CBPO
2189
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $365K | ﹤0.01% |
3,570
| – | – |
|
2190
Ardelyx
ARDX
$988M
| $361K | ﹤0.01% |
+52,166
| New | +$363K |
|
2191
ProPetro Holding
PUMP
$1.35B
| $361K | ﹤0.01% |
70,180
-10,359
| -13% | -$47.7K |
|
|
HAPN
2192
Happen Inc
HAPN
$2.24B
| $355K | ﹤0.01% |
78,097
+9,344
| +14% | +$58.2K |
|
2193
Paysign
PAYS
$698M
| $353K | ﹤0.01% |
36,400
+14,900
| +69% | +$110K |
|
2194
McEwen Inc
MUX
$1.18B
| $351K | ﹤0.01% |
34,760
-13,620
| -28% | -$126K |
|
2195
iHeartMedia
IHRT
$583M
| $351K | ﹤0.01% |
42,000
+11,900
| +40% | +$92.7K |
|
|
NEX
2196
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $350K | ﹤0.01% |
143,059
+16,194
| +13% | +$39.6K |
|
|
SRG
2197
Seritage Growth Properties
SRG
$136M
| $350K | ﹤0.01% |
30,664
-94,309
| -75% | -$949K |
|
|
NFBK
2198
DELISTED
Northfield Bancorp
NFBK
| $349K | ﹤0.01% |
30,282
-14,900
| -33% | -$162K |
|
|
COWN
2199
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $348K | ﹤0.01% |
21,496
-8,598
| -29% | -$104K |
|
|
NOVA
2200
DELISTED
Sunnova Energy
NOVA
| $348K | ﹤0.01% |
+20,400
| New | +$289K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.